The anti‐angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts
Kathrin Rychli(University of Veterinary Medicine Vienna), Johann Wojta(Medical University of Vienna), Philipp J. Hohensinner(Ludwig Boltzmann Institute for Age Research), Bruno K. Podesser(Ludwig Boltzmann Institute for Cardiovascular Research), Gerald Maurer(European Society of Radiology), Stefan Pfaffenberger(Medical University of Vienna), Michael Bauer(Jena University Hospital), Kurt Huber(Sigmund Freud Privatuniversität Wien), Adrian J. Dorfner(Medical University of Vienna), Alexander Niessner, Christoph Kaun(University of Vienna), Wolfgang Dietl(Ludwig Boltzmann Institute for Cardiovascular Research)
Cited by 49
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k